Minitab Authorized Partner Scientific Formosa Inc

Minitab is the leading provider of software and services for quality improvement and statistics education. More than 90% of Fortune 100 companies use Minitab Statistical Software.
Scientific Formosa Inc. is a leading professional software distributor in Taiwan. Major business areas include distributing various application software packages, planning integrated solutions, and providing solid technical support to enterprise clients.

MITEK LAB CO.,LTD

IVD、cell therapy

Molsentech

Molsentech owns advanced semiconductor biochip, biological signal reading, high-throughput data analysis and other cross-field integration technologies, to develops non-invasive biochips that can be detected in real time, and provides emerging products with high sensitivity in the global detection market.The company was established in 2014. The core team comes from the Institute of Physics, Academia Sinica. It is the first team to invest in biological nano-component research in Taiwan, with more than 20 years of research and development experience. Molsentech adheres to the concept of innovation and integration, links the industry chain, and creates a semiconductor biochip industry ecosystem, deploys smart medical care, and will implement precision medicine in the future to become everyone's health guardian.

MSD

Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide. From Merck’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. In 2020 Merck had sales of more than $48 billion and we operate in more than 140 countries.

MycoMagic Biotechnology Co., Ltd.

GMI

National Health Research Institutes

The National Health Research Institutes (NHRI) is a non-profit foundation established by the government with its organization charter created by an Act of Congress (Legislative Yuan) and signed in 1995 by President Teng-hui Lee. Being an autonomous research organization under the supervision of the Department of Health, Executive Yuan, the NHRI is dedicated to the enhancement of medical research and the improvement of health care in this country.

Scientists at the NHRI conduct mission-oriented medical research and investigate many aspects of the basic biomedical sciences, as well as specific diseases. These range from the common problems such as aging, cancer, infectious diseases, mental disorders, occupational diseases, to health policy. It is our hope that the knowledge, experience, and facilities at the NHRI will become important resources to the whole nation in understanding, preventing, and curing diseases. There are several collaborative research projects between the NHRI and medical centers and hospitals. It is anticipated that both public and private sector efforts of the NHRI will help achieve excellence in medical research in Taiwan.

For more information, please visit https://www.nhri.edu.tw/eng/

Nebulum Technologies

Nebulum Technologies is a start-up company focusing on the development of 3D pathology imaging technologies, with the goal of providing more comprehensive and accurate information for drug development and disease diagnosis.
With integration of proprietary tissue clearing, labeling, light-sheet microscope, and data analysis technologies, we provide state-of-the-art 3D pathology CRO services for clients in academic and medical research.

Panion & BF Biotech Inc.

待補

PharmaEssentia Corp.

PharmaEssentia creates novel product- Ropeginterferon alfa-2b for better disease treatment. Compared with similar drugs on the market, the long-acting, mono-pegylated proline interferon with improved pharmacokinetic properties allowing once every two weeks administration offering improved tolerability and convenience. The marketing authorization for Ropeginterferon alfa-2b for treatment of Polycythemia Vera (PV) is granted by EMA in 2019 and Taiwan in May 2020.

Pharmigene, Inc.

PharmiGene Inc. focuses on pharmacogenetics, providing genetic test of personalized medicine to help people finding their optimal medecines and avoiding side effects. We provides common medications for children gene testing, NSAIDs gene testing, cardiovascular disease drug gene testing, epilepsy drug gene testing and Baktar gene testing.
PharmiGene Ltd. also holds patents of carbamazepine, allopurinol and Warfarin gene testing. We developed these tests to IVD and having multinational license, ISO 13485 and GMP certified.
Besides, PharmiGene Ltd. is agency of 10X genomics, Lexogen, Bionano Genomics, Swift Bioscience, Varsome and GenDx in Taiwan. We provides solutions of single cell sequencing, spatiail transcriptome, RNA library and DNA library.